Skip to main content

Table 2 Description of delivery settings that were defined for the purpose of modelling uterotonic coverage in status quo and intervention scenarios. The uterotonics used for prevention of PPH (in non-operative deliveries) at each setting in status quo and intervention scenarios are specified

From: Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings

  Setting 1 Setting 2 Setting 3 Setting 4 Setting 5
Tertiary-level public facilities Secondary-level public facilities Primary health facilities and non-facility births attended by a skilled provider Non-facility births not attended by a skilled provider Private sector deliveries
Settings included in each country
Bangladesh Medical Colleges, Specialised hospitals, District hospitals Upazilla health complex, Maternal and child welfare centres Union sub-centres, Rural sub-centres, Union health and family welfare centres, Community clinics, out-of-facility deliveries attended by a medically trained provider Out-of-facility deliveries attended by a TBA, trained TBA, relative, no-one or other. Private healthcare facilities
Ethiopia Specialist hospitals, General hospitals, Primary hospitals Health centres Deliveries attended by a HEW (health post or out of facility) Out-of-facility deliveries attended by a TBA, trained TBA, relative, no-one or other. Private healthcare facilities
Uterotonic used for PPH prevention (non-operative deliveries) in status quo
Bangladesh Injectable oxytocin Injectable oxytocin Injectable oxytocin or misoprostol Misoprostol Injectable oxytocin
Ethiopia Injectable oxytocin Injectable oxytocin Misoprostol None Injectable oxytocin
Uterotonic used for PPH prevention (non-operative deliveries) in intervention scenarioa
Bangladesh Inhaled oxytocin Inhaled oxytocin Inhaled oxytocin Inhaled oxytocin Injectable oxytocin
Ethiopia Inhaled oxytocin Inhaled oxytocin Inhaled oxytocin None Injectable oxytocin
  1. HEW health extension worker, PPH postpartum haemorrhage, TBA traditional birth attendant
  2. aIn intervention scenario, injectable oxytocin continues to be used for operative deliveries, while inhaled oxytocin is used for non-operative deliveries in settings where roll out is modelled. See appendix (Additional file 1) for estimates of operative delivery rates in each delivery setting